Pharmaceutical research, Pharmacology and Safety

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Pharmaceutical research

Pharmacology

Safety

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

SEPTEMBER 22, 2023

7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile. While favourable safety has been reported up to the Phase II, the relevance of targeting the C-terminal portion of Abeta still needs to be confirmed.

Food and Drug Administration

Food and Drug Administration Safety Patients Leads

Strategies for Streamlining Small Molecule Formulation Development When Bridging from Candidate Selection to First-in-Human Clinical Testing

Pharmaceutical Technology

FEBRUARY 13, 2023

However, there is a high level of attrition during the pharmaceutical research and development process, which is an indicator of the vast number of potential drug substances considered for progression. Therefore, it is vital to choose molecules for pharmaceutical development very carefully.

Food and Drug Administration

Food and Drug Administration Leads Pharmaceutical Pharmaceutical research

Pharma Rep Focus

Paving the way for anti-Abeta active immunotherapy

Strategies for Streamlining Small Molecule Formulation Development When Bridging from Candidate Selection to First-in-Human Clinical Testing

Stay Connected